Minimizing the risk of relapse is essential in multiple sclerosis (MS). As none of the treatments currently available are capable of completely preventing relapses, treatment of these episodes remains a cornerstone of MS care. The objective of this manuscript is to reduce uncertainty and improve quality of care of this neurological process. This article addresses definitions of key concepts, recommendations for clinical examination, classification criteria, magnetic resonance imaging, biomarkers, and specific therapeutic counsels including special populations such as pregnant and breastfeeding women, and children. An algorithm for treating MS relapses is also provided.
Methylprednisolone; Multiple sclerosis; Relapse
Ramo-Tello C, Blanco Y, Brieva L, Casanova B, Martínez-Cáceres E, Ontaneda D, et al. Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses. J Pers Med. 2022 Jan;12:6.
Use this identifier for quote and/or link this documenthttp://hdl.handle.net/11351/7084
This item appears in following collections
- HVH - Articles científics 
The following license files are associated with this item: